Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
48.9M
-
Number of holders
-
5
-
Total 13F shares, excl. options
-
89.1K
-
Shares change
-
+17.7K
-
Total reported value, excl. options
-
$7.09M
-
Value change
-
+$1.41M
-
Number of buys
-
2
-
Number of sells
-
-1
-
Price
-
$79.59
Significant Holders of Axsome Therapeutics, Inc. - Common Stock, $0.0001 par value per share (AXSM) as of Q4 2023
5 filings reported holding AXSM - Axsome Therapeutics, Inc. - Common Stock, $0.0001 par value per share as of Q4 2023.
Axsome Therapeutics, Inc. - Common Stock, $0.0001 par value per share (AXSM) has 5 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 89.1K shares
of 48.9M outstanding shares and own 0.18% of the company stock.
Largest 10 shareholders include RTW INVESTMENTS, LP (4.49M shares), VANGUARD GROUP INC (3.7M shares), BlackRock Inc. (3.24M shares), Fairmount Funds Management LLC (2.36M shares), BVF INC/IL (1.98M shares), CITADEL ADVISORS LLC (1.09M shares), PERCEPTIVE ADVISORS LLC (1.04M shares), Deep Track Capital, LP (1M shares), RA CAPITAL MANAGEMENT, L.P. (1M shares), and STATE STREET CORP (924K shares).
This table shows the top 5 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.